Korro Bio, Inc. Stock Option, Exercise Price, Decrease
Korro Bio, Inc. (KRRO) reported Stock Option, Exercise Price, Decrease of $2.14 per share for the 1-month period ending 2022-08-17, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockOptionExercisePriceDecrease · last filed 2023-11-02
- 2022-08-17: Stock Option, Exercise Price, Decrease $2.14; Stock Option, Exercise Price, Decrease 1 month $2.14.
| Period end | Stock Option, Exercise Price, Decrease | Stock Option, Exercise Price, Decrease 1 month |
|---|---|---|
| 2022-08-17 | $2.14 10-Q · filed 2023-11-02 | $2.14 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |